Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
Open Access
- 28 July 2023
- journal article
- research article
- Published by Medical Journals Sweden AB in Acta Oncologica
- Vol. 62 (8) , 897-906
Abstract
Background: To date, anal cancer patients are treated with radiotherapy to similar volumes despite a marked difference in risk profile based on tumor location and stage. A more individualized approach to delineation of the elective clinical target volume (CTVe) could potentially provide better oncological outcomes as well as improved quality of life. The aim of the present work was to establish Nordic Anal Cancer (NOAC) group guidelines for delineation of the CTVe in anal cancer.Methods: First, 12 radiation oncologists reviewed the literature in one of the following four areas: (1) previous delineation guidelines; (2) patterns of recurrence; (3) anatomical studies; (4) common iliac and para-aortic recurrences and delineation guidelines. Second, areas of controversy were identified and discussed with the aim of reaching consensus.Results: We present consensus-based recommendations for CTVe delineation in anal cancer regarding (a) which regions to include, and (b) how the regions should be delineated. Some of our recommendations deviate from current international guidelines. For instance, the posterolateral part of the inguinal region is excluded, decreasing the volume of irradiated normal tissue. For the external iliac region and the cranial border of the CTVe, we agreed on specifying two different recommendations, both considered acceptable. One of these recommendations is novel and risk-adapted; the external iliac region is omitted for low-risk patients, and several different cranial borders are used depending on the individual level of risk.Conclusion: We present NOAC consensus guidelines for delineation of the CTVe in anal cancer, including a risk-adapted strategy.Keywords
This publication has 44 references indexed in Scilit:
- Australasian Gastrointestinal Trials Group (AGITG) Contouring Atlas and Planning Guidelines for Intensity-Modulated Radiotherapy in Anal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Chemoradiotherapy of Anal Carcinoma: Survival and Recurrence in an Unselected National CohortInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Twenty-Five-Year Experience With Radical Chemoradiation for Anal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Anal Canal Cancer: Management of Inguinal Nodes and Benefit of Prophylactic Inguinal Irradiation (CORS-03 Study)International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Squamous Cell Carcinoma of the Anal Canal: Patterns and Predictors of Failure and Implications for Intensity-Modulated Radiation Treatment PlanningInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Intensity-Modulated Radiation Therapy for the Treatment of Squamous Cell Anal Cancer With Para-aortic Nodal InvolvementInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Anatomical bases for the radiological delineation of lymph node areas. Part III: Pelvis and lower limbsRadiotherapy and Oncology, 2009
- Elective Clinical Target Volumes for Conformal Therapy in Anorectal Cancer: A Radiation Therapy Oncology Group Consensus Panel Contouring AtlasInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- A verification study of proposed pelvic lymph node localisation guidelines using nanoparticle-enhanced magnetic resonance imagingRadiotherapy and Oncology, 2008
- Predictors and Patterns of Recurrence After Definitive Chemoradiation for Anal CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007